{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:08:48Z","timestamp":1771272528858,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100021069","name":"Indivior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.dadr.2024.100220","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T09:12:36Z","timestamp":1707901956000},"page":"100220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Opioid use disorder (OUD) and treatment for opioid problems among OUD symptom subtypes in individuals misusing opioids"],"prefix":"10.1016","volume":"10","author":[{"given":"Emily A.","family":"Miller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela M.","family":"DeVeaugh-Geiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard D.","family":"Chilcoat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dadr.2024.100220_bib1","unstructured":"American Psychiatric Association, 1994. Fourth Edition. American Psychiatric Association,. 10.1176\/appi.books.9780890420614.dsm-iv."},{"key":"10.1016\/j.dadr.2024.100220_bib2","unstructured":"American Psychiatric Association, 2013. Fifth Edition. American Psychiatric Association. 10.1176\/appi.books.9780890425596."},{"key":"10.1016\/j.dadr.2024.100220_bib3","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1377\/hlthaff.2020.02261","article-title":"Addressing racial and ethnic disparities in the use of medications for opioid use disorder: study examines racial and ethnic disparities in the use of medications for opioid use disorder","volume":"40","author":"Andraka-Christou","year":"2021","journal-title":"Health Affairs"},{"key":"10.1016\/j.dadr.2024.100220_bib4","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMsa2212412","article-title":"Racial inequality in receipt of medications for opioid use disorder","volume":"388","author":"Barnett","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.dadr.2024.100220_bib5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev-statistics-011516-012958","article-title":"Are survey weights needed? A review of diagnostic tests in regression analysis","volume":"3","author":"Bollen","year":"2016","journal-title":"Annu. Rev. Stat. Appl."},{"key":"10.1016\/j.dadr.2024.100220_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jpsychires.2016.05.007","article-title":"Exploring the latent trait of opioid use disorder criteria among frequent nonmedical prescription opioid users","volume":"80","author":"Castaldelli-Maia","year":"2016","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.dadr.2024.100220_bib7","article-title":"Racial\/ethnic disparities in the availability of hospital based opioid use disorder treatment","volume":"138","author":"Chang","year":"2022","journal-title":"JSAT"},{"key":"10.1016\/j.dadr.2024.100220_bib8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.amepre.2019.05.017","article-title":"Prescription opioid misuse associated with risk behaviors among adolescents","volume":"57","author":"Clayton","year":"2019","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.dadr.2024.100220_bib9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.drugalcdep.2013.02.036","article-title":"Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol","volume":"132","author":"Compton","year":"2013","journal-title":"Drug Alcohol Depend Rep."},{"key":"10.1016\/j.dadr.2024.100220_bib10","unstructured":"Curtin, S.C., Tejada-Vera, Betzaida, Warmer, M., 2017. Drug overdose deaths among adolescents aged 15\u201319 in the United States: 1999\u20132015. (NCHS Data Brief No. 282). National Center for Health Statistics, Hyattsville, MD."},{"key":"10.1016\/j.dadr.2024.100220_bib11","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.amepre.2022.05.006","article-title":"Racial-Ethnic disparities of buprenorphine and vivitrol receipt in Medicaid","volume":"63","author":"Dunphy","year":"2022","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.dadr.2024.100220_bib12","unstructured":"Dziak, J.J., Bray, B.C., & Wagner, A.T., 2017. LCA_Distal_BCH SAS macro users\u2019 guide (Version 1.1). The Methodology Center, Penn State University. \u3008http:\/\/methodology.psu.edu\u3009."},{"key":"10.1016\/j.dadr.2024.100220_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/mpr.232","article-title":"Understanding the patterns and distribution of opioid analgesic dependence symptoms using a latent empirical approach","volume":"17","author":"Ghandour","year":"2008","journal-title":"Int. J. Methods Psych. Res."},{"key":"10.1016\/j.dadr.2024.100220_bib14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s13311-019-00791-8","article-title":"Opioid craving in human laboratory settings: a review of the challenges and limitations","volume":"17","author":"Goodyear","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.dadr.2024.100220_bib15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.drugalcdep.2011.09.005","article-title":"Analyses related to the development of DSM-5 criteria for substance use related disorders: 2. Proposed DSM-5 criteria for alcohol, cannabis, cocaine and heroin disorders in 663 substance abuse patients","volume":"122","author":"Hasin","year":"2012","journal-title":"Drug Alcohol Depend Rep."},{"key":"10.1016\/j.dadr.2024.100220_bib16","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1176\/appi.ajp.2013.12060782","article-title":"DSM-5 Criteria for substance use disorders: recommendations and rationale","volume":"170","author":"Hasin","year":"2013","journal-title":"AJP"},{"key":"10.1016\/j.dadr.2024.100220_bib17","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.27488","article-title":"Use of medication for opioid use disorder among adults with past-year opioid use disorder in the US, 2021","volume":"6","author":"Jones","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.dadr.2024.100220_bib18","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3389\/fpsyt.2019.00592","article-title":"Craving in opioid use disorder: From neurobiology to clinical practice","volume":"10","author":"Kakko","year":"2019","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.dadr.2024.100220_bib19","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2019.0876","article-title":"Buprenorphine treatment divide by race\/ethnicity and payment","volume":"76","author":"Lagisetty","year":"2019","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.dadr.2024.100220_bib20","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1097\/QAD.0000000000003051","article-title":"Opioid use disorder: a neglected human immunodeficiency virus risk in American adolescents","volume":"35","author":"Lloyd","year":"2021","journal-title":"AIDS"},{"key":"10.1016\/j.dadr.2024.100220_bib21","article-title":"The association of opioid use disorder and homelessness nationally in the Veterans Health Administration","volume":"223","author":"Manhapra","year":"2021","journal-title":"Drug Alcohol Depend Rep."},{"key":"10.1016\/j.dadr.2024.100220_bib22","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/add.14546","article-title":"Measurement-based care using DSM-5 for opioid use disorder: can we make opioid medication treatment more effective?","volume":"114","author":"Marsden","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.dadr.2024.100220_bib23","unstructured":"Maruschak, L.M., Minton, T.D., & Zeng, Z., 2023, April. Opioid use disorder screening and treatment in local jails, 2019. U. S. Department of Justice, Office of Justice Programs, Bureau of Justice Statistics. \u3008https:\/\/bjs.ojp.gov\/document\/oudstlj19.pdf\u3009."},{"key":"10.1016\/j.dadr.2024.100220_bib24","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.3821","article-title":"Use of medication for opioid use disorder among US adolescents and adults with need for opioid treatment, 2019","volume":"5","author":"Mauro","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.dadr.2024.100220_bib25","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1360-0443.2010.03340.x","article-title":"An evaluation of the proposed DSM-5 alcohol use disorder criteria using Australian national data","volume":"106","author":"Mewton","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.dadr.2024.100220_bib26","article-title":"Age disparities in six-month treatment retention for opioid use disorder","volume":"213","author":"Mintz","year":"2020","journal-title":"Drug Alcohol Depend Rep."},{"key":"10.1016\/j.dadr.2024.100220_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240298","article-title":"Private health insurance coverage of drug use disorder treatment: 2005\u20132018","volume":"15","author":"Mojtabai","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.dadr.2024.100220_bib28","unstructured":"National Institute on Drug Abuse, 2023, June 30. Drug Overdose Death Rates. CDC WONDER. \u3008https:\/\/nida.nih.gov\/drug-topics\/trends-statistics\/overdose-death-rates\u3009."},{"key":"10.1016\/j.dadr.2024.100220_bib29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11414-020-09738-w","article-title":"Medicaid expansion and low-income adults with substance use disorders","volume":"48","author":"Olfson","year":"2021","journal-title":"J. Behav. Health Serv. Res."},{"key":"10.1016\/j.dadr.2024.100220_bib30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.dr.2016.06.004","article-title":"Measurement invariance conventions and reporting: the state of the art and future directions for psychological research","volume":"41","author":"Putnick","year":"2016","journal-title":"Dev. Rev."},{"key":"10.1016\/j.dadr.2024.100220_bib31","unstructured":"SHADAC, 2023. Analysis of Health Insurance Coverage Type, 2021. \u3008https:\/\/statehealthcompare.shadac.org\u3009."},{"key":"10.1016\/j.dadr.2024.100220_bib32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11916-022-01010-4","article-title":"Opioid use disorder and racial\/ethnic health disparities: prevention and management","volume":"26","author":"Siddiqui","year":"2022","journal-title":"Curr. Pain. Headache Rep."},{"key":"10.1016\/j.dadr.2024.100220_bib33","first-page":"545","article-title":"Impact of Medicaid, race\/ethnicity, and criminal justice referral on opioid use disorder treatment","volume":"50","author":"Sledge","year":"2022","journal-title":"J. Am. Acad. Psychiatr. Law"},{"key":"10.1016\/j.dadr.2024.100220_bib34","unstructured":"Substance Abuse and Mental Health Services Administration, 2018. 2018 National Survey on Drug Use and Health Methodological Summary and Definitions. \u3008https:\/\/www.samhsa.gov\/data\/\u3009."},{"key":"10.1016\/j.dadr.2024.100220_bib35","unstructured":"Substance Abuse and Mental Health Services Administration, 2020. The opioid crisis and the Black\/African American population: An urgent issue (Publication No. PEP20-05-02-001). \u3008https:\/\/store.samhsa.gov\/sites\/default\/files\/pep20-05-02-001.pdf\u3009."},{"key":"10.1016\/j.dadr.2024.100220_bib36","unstructured":"Substance Abuse and Mental Health Services Administration, 2021. National Survey on Drug Use and Health. \u3008https:\/\/www.samhsa.gov\/data\/data-we-collect\/nsduh-national-survey-drug-use-and-health\u3009."},{"key":"10.1016\/j.dadr.2024.100220_bib37","unstructured":"Substance Abuse and Mental Health Services Administration, 2022. Key substance use and mental health indicators in the United States: Results from the 2021 National Survey on Drug Use and Health (HHS Publication No. PEP22-07-01-005, NSDUH Series H-57). \u3008https:\/\/www.samhsa.gov\/data\/report\/2021-nsduh-annual-national-report\u3009."},{"key":"10.1016\/j.dadr.2024.100220_bib38","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000369338","article-title":"Latent class analysis of DSM-5 criteria for opioid use disorders: results from the Iranian National Survey on Mental Health","volume":"21","author":"Tarrahi","year":"2015","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.dadr.2024.100220_bib39","unstructured":"U.S. Centers for Medicare & Medicaid Services, 2023. Mental health and substance abuse health coverage options. \u3008https:\/\/www.healthcare.gov\/coverage\/mental-health-substance-abuse-coverage\/\u3009."},{"key":"10.1016\/j.dadr.2024.100220_bib40","unstructured":"United Nations Office on Drugs and Crime, 2023. World Drug Report 2023. \u3008www.unodc.org\/unodc\/en\/data-and-analysis\/world-drug-report-2023.html\u3009."},{"key":"10.1016\/j.dadr.2024.100220_bib41","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/jamapsychiatry.2022.1240","article-title":"Association of drug cues and craving with drug use and relapse: a Systematic Review and Meta-analysis","volume":"79","author":"Vafaie","year":"2022","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.dadr.2024.100220_bib42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/0095798420930932","article-title":"Latent class analysis: a guide to best practice","volume":"46","author":"Weller","year":"2020","journal-title":"J Black Psychol."},{"key":"10.1016\/j.dadr.2024.100220_bib43","article-title":"Trends and age-related disparities in opioid use disorder treatment admissions for adolescents and young adults","volume":"132","author":"Welsh","year":"2022","journal-title":"JSAT"},{"key":"10.1016\/j.dadr.2024.100220_bib44","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1017\/S0033291710000954","article-title":"Abuse and dependence on prescription opioids in adults: a mixture categorical and dimensional approach to diagnostic classification","volume":"41","author":"Wu","year":"2011","journal-title":"Psychol. Med."},{"key":"10.1016\/j.dadr.2024.100220_bib45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.drugalcdep.2016.10.015","article-title":"Treatment utilization among persons with opioid use disorder in the United States","volume":"169","author":"Wu","year":"2016","journal-title":"Drug. Alcohol Depend. Rep."},{"key":"10.1016\/j.dadr.2024.100220_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2019.112585","article-title":"Association between homelessness and opioid overdose and opioid-related hospital admissions\/emergency department visits","volume":"242","author":"Yamamoto","year":"2019","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.dadr.2024.100220_bib47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s40124-018-0161-z","article-title":"Opioid use disorders in adolescents\u2014updates in assessment and management","volume":"6","author":"Yule","year":"2018","journal-title":"Curr. Pediatr. Rep."}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724624000040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724624000040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T12:33:13Z","timestamp":1757421193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724624000040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":47,"alternative-id":["S2772724624000040"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2024.100220","relation":{},"ISSN":["2772-7246"],"issn-type":[{"value":"2772-7246","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioid use disorder (OUD) and treatment for opioid problems among OUD symptom subtypes in individuals misusing opioids","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2024.100220","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100220"}}